InvestorsHub Logo

xoc

Followers 13
Posts 304
Boards Moderated 0
Alias Born 04/20/2010

xoc

Re: None

Saturday, 04/19/2014 2:41:20 PM

Saturday, April 19, 2014 2:41:20 PM

Post# of 403528
Please note in the article I referenced he was the senior author expounding in the New England J of Med on the benefit of crizotinib with examples from cases from a phase 1 trial. I hope soon kevetrin will likewise be given its due accolade .
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News